Načítá se...
COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
BACKGROUND: We previously summarized outcomes for 46 cladribine tablets (CladT)-treated patients with multiple sclerosis (MS) and confirmed or suspected COVID-19, as reported to the Merck KGaA Global Patient Safety Database. This report updates on these findings, to 15 January 2021, for a total of 2...
Uloženo v:
| Vydáno v: | Mult Scler Relat Disord |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Author(s). Published by Elsevier B.V.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7997846/ https://ncbi.nlm.nih.gov/pubmed/33813097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.102929 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|